239 related articles for article (PubMed ID: 24179562)
1. Molecular assays for determining Mycobacterium leprae viability in tissues of experimentally infected mice.
Davis GL; Ray NA; Lahiri R; Gillis TP; Krahenbuhl JL; Williams DL; Adams LB
PLoS Negl Trop Dis; 2013; 7(8):e2404. PubMed ID: 24179562
[TBL] [Abstract][Full Text] [Related]
2. Molecular determination of Mycobacterium leprae viability by use of real-time PCR.
Martinez AN; Lahiri R; Pittman TL; Scollard D; Truman R; Moraes MO; Williams DL
J Clin Microbiol; 2009 Jul; 47(7):2124-30. PubMed ID: 19439537
[TBL] [Abstract][Full Text] [Related]
3. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Araujo S; Goulart LR; Truman RW; Goulart IMB; Vissa V; Li W; Matsuoka M; Suffys P; Fontes AB; Rosa PS; Scollard DM; Williams DL
PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005506. PubMed ID: 28570560
[TBL] [Abstract][Full Text] [Related]
4. Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy.
Lenz SM; Collins JH; Ray NA; Hagge DA; Lahiri R; Adams LB
PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008583. PubMed ID: 32936818
[TBL] [Abstract][Full Text] [Related]
5. Effects of purification and fluorescent staining on viability of Mycobacterium leprae.
Lahiri R; Randhawa B; Krahenbuhl JL
Int J Lepr Other Mycobact Dis; 2005 Sep; 73(3):194-202. PubMed ID: 16830641
[TBL] [Abstract][Full Text] [Related]
6. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
Chakraborty A; Ghosh R; Biswas A
FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
[TBL] [Abstract][Full Text] [Related]
7. Quantitative real-time PCR analysis of Mycobacterium leprae DNA and mRNA in human biopsy material from leprosy and reactional cases.
Lini N; Shankernarayan NP; Dharmalingam K
J Med Microbiol; 2009 Jun; 58(Pt 6):753-759. PubMed ID: 19429751
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of real-time and conventional PCR targeting complex 85 genes for detection of Mycobacterium leprae DNA in skin biopsy samples from patients diagnosed with leprosy.
Martinez AN; Britto CF; Nery JA; Sampaio EP; Jardim MR; Sarno EN; Moraes MO
J Clin Microbiol; 2006 Sep; 44(9):3154-9. PubMed ID: 16954241
[TBL] [Abstract][Full Text] [Related]
9. Optimized protocols for Mycobacterium leprae strain management: frozen stock preservation and maintenance in athymic nude mice.
Trombone AP; Pedrini SC; Diório SM; Belone Ade F; Fachin LR; do Nascimento DC; Rosa PS
J Vis Exp; 2014 Mar; (85):. PubMed ID: 24686247
[TBL] [Abstract][Full Text] [Related]
10. DNA-PCR and RT-PCR for the 18-kDa gene of Mycobacterium leprae to assess the efficacy of multi-drug therapy for leprosy.
Chae GT; Kim MJ; Kang TJ; Lee SB; Shin HK; Kim JP; Ko YH; Kim SH; Kim NH
J Med Microbiol; 2002 May; 51(5):417-422. PubMed ID: 11990494
[TBL] [Abstract][Full Text] [Related]
11. A Sensitive and Quantitative Assay to Enumerate and Measure Mycobacterium leprae Viability in Clinical and Experimental Specimens.
Collins JH; Lenz SM; Ray NA; Balagon MF; Hagge DA; Lahiri R; Adams LB
Curr Protoc; 2022 Feb; 2(2):e359. PubMed ID: 35113486
[TBL] [Abstract][Full Text] [Related]
12. Enumeration of Mycobacterium leprae using real-time PCR.
Truman RW; Andrews PK; Robbins NY; Adams LB; Krahenbuhl JL; Gillis TP
PLoS Negl Trop Dis; 2008; 2(11):e328. PubMed ID: 18982056
[TBL] [Abstract][Full Text] [Related]
13. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae.
Vedithi SC; Malhotra S; Das M; Daniel S; Kishore N; George A; Arumugam S; Rajan L; Ebenezer M; Ascher DB; Arnold E; Blundell TL
Sci Rep; 2018 Mar; 8(1):5016. PubMed ID: 29567948
[TBL] [Abstract][Full Text] [Related]
14. Application of a viability-staining method for Mycobacterium leprae derived from the athymic (nu/nu) mouse foot pad.
Lahiri R; Randhawa B; Krahenbuhl J
J Med Microbiol; 2005 Mar; 54(Pt 3):235-242. PubMed ID: 15713606
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis.
Williams DL; Pittman TL; Gillis TP; Matsuoka M; Kashiwabara Y
J Clin Microbiol; 2001 Jun; 39(6):2083-8. PubMed ID: 11376039
[TBL] [Abstract][Full Text] [Related]
16. Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients.
Chen X; He J; Liu J; You Y; Yuan L; Wen Y
PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007946. PubMed ID: 31881061
[TBL] [Abstract][Full Text] [Related]
17. Mutations in genes related to drug resistance in Mycobacterium leprae isolates from leprosy patients in Korea.
You EY; Kang TJ; Kim SK; Lee SB; Chae GT
J Infect; 2005 Jan; 50(1):6-11. PubMed ID: 15603834
[TBL] [Abstract][Full Text] [Related]
18. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy.
Jamil S; Keer JT; Lucas SB; Dockrell HM; Chiang TJ; Hussain R; Stoker NG
Lancet; 1993 Jul; 342(8866):264-8. PubMed ID: 8101301
[TBL] [Abstract][Full Text] [Related]
19. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
[TBL] [Abstract][Full Text] [Related]
20. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
